CompletedNCT04614597

A Study on Immunity Duration Against Polio Over 18 Months Infants After 2 or 3 Primary Doses Sabin IPV in China

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centers for Disease Control and Prevention, China
Principal Investigator
Zijian Feng, MD
Centers for Disease Control and Prevention, China
Intervention
Sabin strain inactivated polio vaccine(biological)
Enrollment
774 target
Eligibility
3 years · All sexes
Timeline
20202021

Study locations (1)

Collaborators

World Health Organization · Shandong Province Centers for Disease Control and Prevention

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04614597 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials